Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Oct 23 | LIXT Lixte Biotechnology | Common Stock | Buy | Acquire P | No | No | 2.8 | 10,000 | 28.00 k | 11,000 |
26 Sep 23 | LIXT Lixte Biotechnology | Options to Purchase Common Stock Common | Grant | Acquire A | No | No | 1.95 | 250,000 | 487.50 k | 250,000 |
26 Sep 23 | LIXT Lixte Biotechnology | Options to Purchase Common Stock Common | Grant | Acquire A | No | No | 1.95 | 250,000 | 487.50 k | 250,000 |
30 Jun 23 | LIXT Lixte Biotechnology | Options to Purchase Common Stock Common | Grant | Acquire A | No | No | 5.88 | 10,000 | 58.80 k | 10,000 |
17 Jun 22 | LIXT Lixte Biotechnology | Options to Purchase Common Stock Common | Grant | Acquire A | No | No | 7.4 | 25,000 | 185.00 k | 25,000 |